Hjem › Spiserørkreft › Missouri › St. Louis
Kliniske studier for Spiserørkreft i St. Louis, MO
17 studier for Spiserørkreft søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Washington University School of Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
- Washington University School of Medicine in St. Louis, St Louis
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruttererFrivillige helsepersonell ønskes velkommen
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- og 4 flere
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- og 4 flere
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- Washington University, School of Medicine, St Louis
Pan-tumor MRD Study
RekruttererObservasjonsstudie
- Cancer Care Specialists of Illinois (CCSI), O'Fallon · 16 mi unna
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- Washington University, St Louis
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
- Washington University School of Medicine in St. Louis, St Louis
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruttererFase 3
- Research Site, St Louis
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
RekruttererFase 1
- Washington University School of Medicine, St Louis
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Washington University School of Medicine at St Louis, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekruttererFase 1/2
- Saint Louis University, St Louis
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
RekruttererFase 1
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, St Louis
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Washington University, St Louis
Spiserørkreft-studier i andre byer
- Houston, TX36 studier
- Boston, MA23 studier
- New York City, NY22 studier
- Nashville, TN19 studier
- Pittsburgh, PA15 studier
- Los Angeles, CA15 studier
- Baldwin Park, CA14 studier
- Grand Rapids, MI14 studier
- Philadelphia, PA13 studier
- San Antonio, TX12 studier
- Rochester, MN11 studier
- Arlington, VA11 studier
Andre studier i St. Louis
- Ikke-småcellet lungekreft73 studier
- Brystkreft64 studier
- Metastatisk kreft54 studier
- Kolorektal kreft50 studier
- Kreft (alle typer)46 studier
- Prostatakreft46 studier
- Lungekreft39 studier
- Eggstokkreft38 studier
- Pankreaskreft33 studier
- Endometriekreft29 studier
- Plateepitelcancer i hode og hals28 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.